Pregled bibliografske jedinice broj: 1192776
New frontiers in the hunger management involving GLP-1, taste and oestrogen
New frontiers in the hunger management involving GLP-1, taste and oestrogen // Diabetic medicine, 16 (2022), e14846, 2 doi:10.1111/dme.14846 (međunarodna recenzija, pismo uredniku, stručni)
CROSBI ID: 1192776 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
New frontiers in the hunger management involving
GLP-1, taste and oestrogen
Autori
Baretić, Maja
Izvornik
Diabetic medicine (0742-3071) 16
(2022);
E14846, 2
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pismo uredniku, stručni
Ključne riječi
obesity ; oestrogen ; GLP-1 ; therapy
Sažetak
Oestrogens are possible therapeutic option for obesity. Today, their usage is limited due to their female-specific gynaecological action and tumour-promoting properties. There is an option for oestrogen delivery based on a concept of peptide carrier that selectively delivers oestrogen to specific tissues. Improved GLP-1 action could be accomplished by oestrogen receptor-mediated delivery.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb
Profili:
Maja Baretić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
